ASHLEY AGAGLIATI: Open Payments
NPI 1518608512 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 56 payments from 9 companies in 2025. Trend: 2023 $36 · 2024 $63 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $442 |
| ACADIA Pharmaceuticals Inc | 4 | $102 |
| PFIZER INC. | 5 | $90 |
| Vanda Pharmaceuticals Inc. | 3 | $90 |
| Eisai Inc. | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Boston Scientific Corporation | 1 | $27 |
| Lundbeck LLC | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: QULIPTA, UBRELVY, NUPLAZID, PONVORY, Leqembi, NURTEC ODT, KESIMPTA, General - DBS.
Industry payments across PA — which companies pay providers there.
